Bio Path Holdings Inc (BPTH)

[SJSTOCKSHARK]

I do not see how the reverse split benefits the company. Staying on the NASDAQ allows the Russell short to continue unabated from $3.00 back to $.30. Another shorty 10 bagger.

Check out what happened to MRNA after their reverse split. They lost 50% of the stock price since the split in August 2017.

Now that we have 8+ million in the bank again, we have no need to raise funds immediately. We should wait until the FDA looks at our results before doing anything.

GP, a no confidence vote still allows the BOD to operate the company until a replacement BOD is in place.

The unbridled gall of management to propose another compensation plan after the last year performance is unbelievable!

I say make William Hahne, M.D. the CEO and Chairman and let him select who he wants to stay absent PN of course.

I voted to withhold all BOD votes, and No on 2 and 3.